You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 285 No. 24, June 27, 2001 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Original Contribution
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (142)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Sexually Transmitted Diseases
 •Dermatology
 •Dermatologic Disorders
 •Infectious Diseases
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Effect of Condoms on Reducing the Transmission of Herpes Simplex Virus Type 2 From Men to Women

Anna Wald, MD,MPH; Andria G. M. Langenberg, MD; Katherine Link, MS; Allen E. Izu, MS; Rhoda Ashley, PhD; Terri Warren, ARNP; Stephen Tyring, MD,PhD; John M. Douglas, Jr, MD; Lawrence Corey, MD

JAMA. 2001;285:3100-3106.

Context  Herpes simplex virus type 2 (HSV-2) is one of the most common sexually transmitted infections in the United States. No prospective study has shown the ability of condoms to reduce transmission of HSV-2.

Objective  To evaluate risk factors for HSV-2 acquisition and efficacy of condoms in prevention of HSV-2 transmission.

Design  Analysis of data from a randomized, double-blind, placebo-controlled trial conducted December 13, 1993, to June 28, 1996, of an ineffective candidate HSV-2 vaccine with 18 months of follow-up.

Setting  Eighteen clinical trial centers in the United States.

Participants  A total of 528 monogamous couples discordant for HSV-2 infection, including an HSV-2–susceptible population of 261 men and 267 women.

Main Outcome Measure  Acquisition of HSV-2 infection by susceptible partners, compared with those remaining free of HSV-2 with regard to demographic characteristics, sexual activity, and condom use.

Results  Twenty-six women (9.7%) vs 5 men (1.9%) acquired HSV-2, for a rate per 10 000 sex acts (episodes of sexual intercourse) of 8.9 vs 1.5, respectively (P<.001). In multivariable analysis, younger age (adjusted hazard ratio [HR] per 5 years, 1.57; 95% confidence interval [CI], 1.22-2.04), seropositivity for HSV-1 and HSV-2 vs HSV-2 alone in the source partner (adjusted HR, 2.34; 95% CI, 1.14-4.82), and more frequent sexual activity (adjusted HR per additional sex act per week, 1.10; 95% CI, 1.01-1.19) were associated with higher risk of HSV-2 acquisition. Condom use during more than 25% of sex acts was associated with protection against HSV-2 acquisition for women (adjusted HR, 0.085; 95% CI, 0.01-0.67) but not for men (adjusted HR, 2.02; 95% CI, 0.32-12.50). Risk of HSV-2 transmission declined from 8.5 per 100 person-years in the initial 150-day interval to 0.9 per 100 person-years in the final 150-day interval (P = .002 for trend), concurrent with a decrease in sexual activity and proportion of sex acts occurring when the source partner had genital lesions.

Conclusions  Condom use offers significant protection against HSV-2 infection in susceptible women. Changes in sexual behavior, correlated with counseling about avoiding sex when a partner has lesions, were associated with reduction in HSV-2 acquisition over time. These data suggest that identification of discordant couples can reduce transmission of HSV-2, especially for heterosexual couples in which the male partner has HSV-2 infection.


Author Affiliations: Departments of Medicine (Drs Wald and Corey), Epidemiology (Dr Wald), and Laboratory Medicine (Ms Link and Drs Ashley and Corey), University of Washington, Seattle; Chiron Corp, Emeryville, Calif (Dr Langenberg and Mr Izu); Westover Heights Clinic, Portland, Ore (Ms Warren); Departments of Microbiology, Immunology, Dermatology, and Pediatrics, University of Texas, Medical Branch, Galveston (Dr Tyring); Department of Public Health, Denver, Colo (Dr Douglas); and Program in Infectious Diseases, Fred Hutchinson Cancer Research Center, Seattle, Wash (Dr Corey).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTER

Effect of Condoms on Reducing Genital Herpes Transmission
Mary B. Adam, Landon Myer, Joshua R. Mann, Curtis C. Stine, Joe S. McIlhaney, Anna Wald, Katherine Link, Lawrence Corey, and Andria Langenberg
JAMA. 2001;286(17):2095-2096.
EXTRACT | FULL TEXT  

RELATED ARTICLES

June 27, 2001
JAMA. 2001;285(24):3197-3198.
EXTRACT | FULL TEXT  

Genital Herpes
JAMA. 2001;285(24):3212.
PDF  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Herpes simplex virus type 2 and HIV infection among US military personnel: implications for health prevention programmes
Bautista et al.
Int J STD AIDS 2009;20:634-637.
ABSTRACT | FULL TEXT  

A Pooled Analysis of the Effect of Condoms in Preventing HSV-2 Acquisition
Martin et al.
Arch Intern Med 2009;169:1233-1240.
ABSTRACT | FULL TEXT  

Herpes complex
Rietmeijer and Low
Sex. Transm. Infect. 2008;84:330-331.
FULL TEXT  

Herpes simplex virus type 2: epidemiology and management options in developing countries
Paz-Bailey et al.
Postgrad. Med. J. 2008;84:299-306.
ABSTRACT | FULL TEXT  

In search of optimal genital herpes management and standard of care (INSIGHTS): doctors' and patients' perceptions of genital herpes
Romanowski et al.
Sex. Transm. Infect. 2008;84:51-56.
ABSTRACT | FULL TEXT  

Are condoms the answer to rising rates of non-HIV sexually transmitted infection? No
Genuis
BMJ 2008;336:185-185.
FULL TEXT  

Association Between Condom Use at Sexual Debut and Subsequent Sexual Trajectories: A Longitudinal Study Using Biomarkers
Shafii et al.
AJPH 2007;97:1090-1095.
ABSTRACT | FULL TEXT  

Risk of herpes simplex virus type 2 acquisition increases over early adulthood: evidence from a cohort study
Dickson et al.
Sex. Transm. Infect. 2007;83:87-90.
ABSTRACT | FULL TEXT  

Herpes simplex virus type 2: epidemiology and management options in developing countries
Paz-Bailey et al.
Sex. Transm. Infect. 2007;83:16-22.
ABSTRACT | FULL TEXT  

What is the achievable effectiveness of the India AIDS Initiative intervention among female sex workers under target coverage? Model projections from southern India.
Williams et al.
Sex. Transm. Infect. 2006;82:372-380.
ABSTRACT | FULL TEXT  

Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States.
Xu et al.
JAMA 2006;296:964-973.
ABSTRACT | FULL TEXT  

Condom effectiveness for prevention of C trachomatis infection.
Warner et al.
Sex. Transm. Infect. 2006;82:265-265.
FULL TEXT  

The psychosocial impact of serological diagnosis of asymptomatic herpes simplex virus type 2 infection.
Rosenthal et al.
Sex. Transm. Infect. 2006;82:154-157.
ABSTRACT | FULL TEXT  

Modeling the Sexual Transmissibility of Human Papillomavirus Infection using Stochastic Computer Simulation and Empirical Data from a Cohort Study of Young Women in Montreal, Canada
Burchell et al.
Am J Epidemiol 2006;163:534-543.
ABSTRACT | FULL TEXT  

Sex differences in the transmission, prevention, and disease manifestations of sexually transmitted diseases.
Madkan et al.
Arch Dermatol 2006;142:365-370.
ABSTRACT | FULL TEXT  

Sexual behaviour and condom use among individuals with a history of symptomatic genital herpes
Rana et al.
Sex. Transm. Infect. 2006;82:69-74.
ABSTRACT | FULL TEXT  

The Relationship between Condom Use and Herpes Simplex Virus Acquisition
Wald et al.
ANN INTERN MED 2005;143:707-713.
ABSTRACT | FULL TEXT  

An Ounce of Prevention
Hook
ANN INTERN MED 2005;143:751-752.
FULL TEXT  

The psychosocial impact of serological herpes simplex type 2 testing in an urban HIV clinic
Meyer et al.
Sex. Transm. Infect. 2005;81:309-315.
ABSTRACT | FULL TEXT  

Health related quality of life in genital herpes: a pilot comparison of measures
Fisman
Sex. Transm. Infect. 2005;81:267-270.
ABSTRACT | FULL TEXT  

Topical microbicides for the prevention of genital herpes infection
Keller et al.
J Antimicrob Chemother 2005;55:420-423.
ABSTRACT | FULL TEXT  

The Significance of Herpes Simplex for School Nurses
Ensor
The Journal of School Nursing 2005;21:10-16.
ABSTRACT | FULL TEXT  

Patient satisfaction with care for genital herpes: insights from a global survey
Patrick et al.
Sex. Transm. Infect. 2004;80:192-197.
ABSTRACT | FULL TEXT  

Genital Herpes
Kimberlin and Rouse
NEJM 2004;350:1970-1977.
FULL TEXT  

Managing Genital Herpes
JWatch Women's Health 2004;2004:4-4.
FULL TEXT  

Condom Effectiveness for Reducing Transmission of Gonorrhea and Chlamydia: The Importance of Assessing Partner Infection Status
Warner et al.
Am J Epidemiol 2004;159:242-251.
ABSTRACT | FULL TEXT  

Neonatal Herpes Simplex Infection
Kimberlin
Clin. Microbiol. Rev. 2004;17:1-13.
ABSTRACT | FULL TEXT  

Once-Daily Valacyclovir to Reduce the Risk of Transmission of Genital Herpes
Corey et al.
NEJM 2004;350:11-20.
ABSTRACT | FULL TEXT  

A population based study of herpes simplex virus 2 seroprevalence in rural Costa Rica
Rodriguez et al.
Sex. Transm. Infect. 2003;79:460-465.
ABSTRACT | FULL TEXT  

Is HSV serology useful for the management of first episode genital herpes?
Page et al.
Sex. Transm. Infect. 2003;79:276-279.
ABSTRACT | FULL TEXT  

Psychosocial impact of serological diagnosis of herpes simplex virus type 2: a qualitative assessment
Melville et al.
Sex. Transm. Infect. 2003;79:280-285.
ABSTRACT | FULL TEXT  

T Cell Immunity to Herpes Simplex Viruses in Seronegative Subjects: Silent Infection or Acquired Immunity?
Posavad et al.
J. Immunol. 2003;170:4380-4388.
ABSTRACT | FULL TEXT  

Estimating the costs and benefits of screening monogamous, heterosexual couples for unrecognised infection with herpes simplex virus type 2
Fisman et al.
Sex. Transm. Infect. 2003;79:45-52.
ABSTRACT | FULL TEXT  

Male Contraception
Anderson and Baird
Endocr. Rev. 2002;23:735-762.
ABSTRACT | FULL TEXT  

Use of Immunostimulatory Sequence-Containing Oligonucleotides as Topical Therapy for Genital Herpes Simplex Virus Type 2 Infection
Pyles et al.
J. Virol. 2002;76:11387-11396.
ABSTRACT | FULL TEXT  

Using the evidence base on genital herpes: optimising the use of diagnostic tests and information provision
Scoular
Sex. Transm. Infect. 2002;78:160-165.
ABSTRACT | FULL TEXT  

Determinants of STD epidemics: implications for phase appropriate intervention strategies
Aral
Sex. Transm. Infect. 2002;78:i3-13.
ABSTRACT | FULL TEXT  

Effect of Condoms on Reducing Genital Herpes Transmission
Adam et al.
JAMA 2001;286:2095-2096.
FULL TEXT  

Condoms and Genital Herpes
JWatch Infect. Diseases 2001;2001:12-12.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.